{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:29:08Z","timestamp":1787506148881,"version":"build-2736575974"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":582,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2024-04321"],"award-info":[{"award-number":["RGPIN-2024-04321"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN\u20102024\u201004321"],"award-info":[{"award-number":["RGPIN\u20102024\u201004321"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Factors affecting serum concentrations of levetiracetam in dogs are unknown and could affect the efficacy of levetiracetam in controlling seizures in dogs with epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Higher PO doses of levetiracetam will be needed in dogs to achieve serum concentrations shown to be effective in humans. Determine factors that could influence serum levetiracetam concentrations and justify dose adjustment in some epileptic dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Sixty-nine client-owned dogs with epilepsy treated with levetiracetam alone or in combination, based on 127 trough serum concentration measurements of levetiracetam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study. Linear mixed models were used to assess the effect of patient signalment and concurrent drug administration on serum concentrations of levetiracetam and the effect of serum concentration of levetiracetam on seizure frequency reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The PO dose of levetiracetam significantly explained changes in serum levetiracetam concentration, and this causal link was stronger with monotherapy (R2\u2009=\u20090.59, P\u2009&amp;lt;\u2009.001). Phenobarbital significantly decreased serum levetiracetam concentration in a dose dependent manner (R2\u2009=\u20090.30, P\u2009=\u2009.003). Based on our model, a levetiracetam dosage of 99\u2013216\u2009mg\/kg\/day is necessary to obtain a serum levetiracetam concentration of 20\u2009\u03bcg\/mL when used alone or concurrently with 7\u2009mg\/kg\/day of phenobarbital. No other factors were found to influence serum levetiracetam concentrations. No therapeutic range could be identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and Clinical Importance<\/jats:title>\n                    <jats:p>Our data suggest that a dosage of 99\u2013216\u2009mg\/kg\/day of levetiracetam is needed to achieve a serum concentration known to be therapeutically effective in humans, especially when administered concomitantly with phenobarbital.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.17128","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T09:43:00Z","timestamp":1718703780000},"page":"2249-2256","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors influencing serum concentrations of levetiracetam in dogs with epilepsy"],"prefix":"10.1093","volume":"38","author":[{"given":"Marine","family":"Saint-Maxent","sequence":"first","affiliation":[{"name":"D\u00e9partement de Sciences Cliniques, Facult\u00e9 de M\u00e9decine V\u00e9t\u00e9rinaire, Universit\u00e9 de Montr\u00e9al , Saint-Hyacinthe, Quebec,","place":["Canada"]},{"name":"Kleintierklinik, Vetsuisse-Fakult\u00e4t, Universit\u00e4t Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0795-948X","authenticated-orcid":false,"given":"Tristan","family":"Juette","sequence":"additional","affiliation":[{"name":"Vice-d\u00e9canat \u00e0 la Recherche, Facult\u00e9 de M\u00e9decine V\u00e9t\u00e9rinaire, Universit\u00e9 de Montr\u00e9al , Saint-Hyacinthe, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joane","family":"Parent","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Sciences Cliniques, Facult\u00e9 de M\u00e9decine V\u00e9t\u00e9rinaire, Universit\u00e9 de Montr\u00e9al , Saint-Hyacinthe, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Castel","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Sciences Cliniques, Facult\u00e9 de M\u00e9decine V\u00e9t\u00e9rinaire, Universit\u00e9 de Montr\u00e9al , Saint-Hyacinthe, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-1476","authenticated-orcid":false,"given":"Thomas","family":"Parmentier","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Sciences Cliniques, Facult\u00e9 de M\u00e9decine V\u00e9t\u00e9rinaire, Universit\u00e9 de Montr\u00e9al , Saint-Hyacinthe, Quebec,","place":["Canada"]},{"name":"Centre Interdisciplinaire de Recherche sur le Cerveau et L'apprentissage (CIRCA), Universit\u00e9 de Montr\u00e9al , Montreal, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"2026020304085526200_jvim17128-bib-0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.seizure.2014.02.003","article-title":"Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs)","volume":"23","author":"Stepanova","year":"2014","journal-title":"Seizure"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0003","first-page":"240","article-title":"Effective levetiracetam doses and serum concentrations: age effects","volume":"43","author":"Leppik","year":"2002","journal-title":"Epilepsia"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jvim.13841","article-title":"2015 ACVIM small Animal consensus statement on seizure Management in Dogs","volume":"30","author":"Podell","year":"2016","journal-title":"J Vet Intern Med"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/vr.104190","article-title":"Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010\u20132015)","volume":"181","author":"Kelly","year":"2017","journal-title":"Vet Rec"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1939-1676.2011.00866.x","article-title":"Evaluation of Levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial","volume":"26","author":"Mu\u00f1ana","year":"2012","journal-title":"J Vet Intern Med"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0007","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tvjl.2007.03.002","article-title":"The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs","volume":"176","author":"Volk","year":"2008","journal-title":"Vet J"},{"key":"2026020304085526200_jvim17128-bib-0008","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tvjl.2015.10.018","article-title":"A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy","volume":"208","author":"Freds\u00f8","year":"2016","journal-title":"Vet J"},{"key":"2026020304085526200_jvim17128-bib-0009","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12917-015-0464-z","article-title":"International veterinary epilepsy task force consensus proposal: medical treatment of canine epilepsy in Europe","volume":"11","author":"Bhatti","year":"2015","journal-title":"BMC Vet Res"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0010","first-page":"3125","article-title":"Resistance is futile\u201d: a pilot study into Pseudoresistance in canine epilepsy","volume":"13","author":"Kajin","year":"2023","journal-title":"Anim Open Access J MDPI"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0011","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2460\/ajvr.71.3.337","article-title":"Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses","volume":"71","author":"Moore","year":"2010","journal-title":"Am J Vet Res"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0012","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jvim.12548","article-title":"Effect of chronic Administration of Phenobarbital, or bromide, on pharmacokinetics of Levetiracetam in dogs with epilepsy","volume":"29","author":"Mu\u00f1ana","year":"2015","journal-title":"J Vet Intern Med"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0013","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1373\/jalm.2016.022186","article-title":"Validation of an automated assay for Levetiracetam (Keppra) on Vitros 5600","volume":"1","author":"Ali","year":"2017","journal-title":"J Appl Lab Med"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12917-015-0462-1","article-title":"International veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogs","volume":"11","author":"De Risio","year":"2015","journal-title":"BMC Vet Res"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12917-015-0465-y","article-title":"International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy","volume":"11","author":"Potschka","year":"2015","journal-title":"BMC Vet Res"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0016","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2460\/javma.1998.213.10.1449","article-title":"Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996)","volume":"213","author":"Trepanier","year":"1998","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.pediatrneurol.2015.01.012","article-title":"Correlation between efficacy of Levetiracetam and serum levels among children with refractory epilepsy","volume":"52","author":"Sheinberg","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2026020304085526200_jvim17128-bib-0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2885.2010.01188.x","article-title":"The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital","volume":"34","author":"Moore","year":"2011","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020304085526200_jvim17128-bib-0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12917-015-0340-x","article-title":"Assessment into the usage of levetiracetam in a canine epilepsy clinic","volume":"11","author":"Packer","year":"2015","journal-title":"BMC Vet Res"},{"key":"2026020304085526200_jvim17128-bib-0020","first-page":"410","article-title":"Levetiracetam therapy for long-term idiopathic epileptic dogs","volume":"18","author":"Steinberg","year":"2004","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/38\/4\/2249\/66663930\/jvim17128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/38\/4\/2249\/66663930\/jvim17128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:09:09Z","timestamp":1770109749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/38\/4\/2249\/8448781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.17128","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"2024-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}